Astellas Pharma
978-613-3-85385-0
6133853859
80
2010-11-09
34.00 €
eng
https://images.our-assets.com/cover/230x230/9786133853850.jpg
https://images.our-assets.com/fullcover/230x230/9786133853850.jpg
https://images.our-assets.com/cover/2000x/9786133853850.jpg
https://images.our-assets.com/fullcover/2000x/9786133853850.jpg
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Astellas Pharma Inc. is a Japanese pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas' franchise areas are urology, immunology (transplantation), dermatology, cardiology, and infectious disease. Priority areas for R&D are infectious diseases, diabetes, gastrointestinal diseases, oncology, and diseases of the central nervous system. The company's headquarters are in Tokyo, with research centres in Tsukuba and Osaka. Clinical development is centred in Deerfield, Illinois and Leiderdorp, Netherlands. Combined revenues of the two pre-merger companies were $7.9 billion in 2004. Worldwide the company employs about 17,000 people.
https://morebooks.de/books/tr/published_by/alphascript-publishing/2/products
Eczacılık
https://morebooks.de/store/tr/book/astellas-pharma/isbn/978-613-3-85385-0